C-reactive protein levels among hypertensive patients attending University of Nigeria Teaching Hospital Ituku-ozalla, Enugu State, Nigeria

  • Kelvin Nkemakonam Orji
  • Cyprian Emeka Oguji
  • Ujunwa Frances Onyeama
  • et al.
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

The blood level of C-reactive protein (CRP) has been postulated to increase in hypertensive patients but has not been implicated as a risk factor for high blood pressure. This prompted this study to investigate the level of CRP of hypertensive patients at the University of Nigeria Teaching Hospital, Ituku-Ozalla, and Enugu state. Eighty-nine subjects of which 50 were hypertensive patients (test subjects) and 39 apparently healthy individuals (control subjects) volunteered in the study. A structured questionnaire was used to capture the bio-data and other vital information from the participants of which virtually all the test subjects were on anti-hypertensive drugs. Anthropometric measurements were taken, blood samples were collected and CRP was analyzed using the Enzyme-Linked Immunosorbent Assay method. Data were analyzed using the student's test and Analysis of Variance (ANOVA). There was no significant statistical difference (P>0.05) in CRP levels (µg/ml) in all the comparisons; that is between all male and female study populations (401-478 and 3.61-4.24), between tests and controls (3.62-3.85 and 4.06-526), between male tests and male controls (3.76-3.55 and 4.24-5.80), between female tests and female control (3.62 ±3.85 and 3.76-3.55) between male tests and female tests (3.50-414 and 381-4.531, and between male controls and female controls (4.24 ±5.80 and 3.81-4.55). It was also observed that there was no relationship between the duration of hypertension with the CRP levels in the test subjects. These results suggest that the C-reactive protein levels may be increased in hypertensive patients but may be decreased by antihypertensive therapies. More studies are needed and these findings warrant further evaluation in randomized trials. A longitudinal study to fully assess the effect of antihypertensive drugs on the level of C-reactive protein in hypertensive patients may also be of great essence.

Cite

CITATION STYLE

APA

Kelvin Nkemakonam Orji, Cyprian Emeka Oguji, Ujunwa Frances Onyeama, Moses Ejiofor Agbo, Favour Chizaram Sunday, Victor Chisom Makata, … Innocent Nwabueze Okonkwo. (2022). C-reactive protein levels among hypertensive patients attending University of Nigeria Teaching Hospital Ituku-ozalla, Enugu State, Nigeria. GSC Biological and Pharmaceutical Sciences, 19(3), 083–092. https://doi.org/10.30574/gscbps.2022.19.3.0210

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free